Progress in the treatment and outcome of pediatric inflammatory bowel disease patients

• This review discusses how treatment of pediatric inflammatory bowel disease (IBD) patients has improved with attention to therapeutic quality and cost. The number of such patients in Western countries has increased rapidly. Similarly to what has been the trend in the management of adult IBD, the pediatric IBD therapy has become more active than earlier. High use of immunosuppressants has helped to control the extensive and aggressive course of pediatric IBD. Full disease control already at an early phase has advantages such as to preserve normal child growth and development, to maintain overall good health and quality of life, as well as to decrease the psychosocial burden of the disease. A key research direction is to develop the more active approach into a way to reduce healthcare costs by decreasing the so-far high rate of surgery of pediatric IBD patients. 

Nyckelord

inflammatory bowel disease

outcome

progress

management

patient

family

cost

benefit

Människan i vården

The Human Perspective in Care

Publikations- och innehållstyp

ref (ämneskategori)

for (ämneskategori)